-
Dow Europe GmbH Announces Epoxy Products Price Increases in Europe, Middle East, Africa and IndiaHORGEN, Switzerland--(BUSINESS WIRE)--Effective May 1, 2010 or as contract terms allow, Dow Europe GmbH will increase the price of all its epoxy resins by 300 Euro/MT in Europe (including Turkey), and2010/5/12
-
ISP Pharmaceuticals Announces Excipients & Coatings Technical SeminarWayne, NJ (May 5, 2010) – ISP Pharmaceuticals today announced it will hold a technical seminar in Karachi, Pakistan, May 19th on the subject of excipients and coatings. The free daylong progra2010/5/12
-
BASF raises prices for all Polyetheramines globallyEffective immediately or as existing contracts allow, BASF is raising prices for its Polyetheramines portfolio globally by 100 Euros per metric ton or the equivalent amount in local currency. Polye2010/5/12
-
Innovative but Practical Technologies to Tame Difficult APIs for Formulation Development & GMP ManufactureBiopharmaceuticals are becoming more complex and, by association, the physical characteristics are becoming more challenging, leading to the need for more careful handling and processing. This talk wi2010/5/11
-
The Importance Of The Freeman Technology FT4 As An Essential Tool For Powder CharacterisationThe recent installation of a FT4 universal powder tester from Freeman Technology at Rutgers, The State University of New Jersey, in the USA, reflects the increasing adoption of the system by those wor2010/5/11
-
Coalition For Vaccine Safety (CVS) Calls On FDA Commissioner To Immediately Suspend All Contaminated Rotavirus VaccinesFDA Expert Advisory Panel Fails to Follow Safety First Agenda for Childhood Vaccines Containing DNA from Pig Viruses Washington/PRNewswire-USNewswire/ -- On Friday, the Food and Drug Administration (2010/5/11
-
Daisy Data Displays' 5550 Series Receives FM ApprovalDaisy Data Displays, Inc.(D3), industry leader in developing specialized and ruggedized computers, displays, and keyboards designed to endure harsh industrial and plant environments, announced the2010/5/10
-
Watson Confirms SIMCOR® Patent ChallengeMorristown, NJ./PRNewswire-FirstCall/ - Watson Pharmaceuticals, Inc. (NYSE: WPI) today confirmed that its subsidiary, Watson Laboratories, Inc. - Florida, filed an Abbreviated New Drug Application (AN2010/5/7
-
Sinovac Submits Clinical Trial Application For Mumps Vaccine To SFDAFirst Live Attenuated Vaccine to be Submitted by Sinovac to SFDA for Clinical Trials First Vaccine from Sinovac Dalian's Development Pipeline Accepted by SFDA Following Joint Venture's Formation in2010/5/7
-
Osiris Therapeutics Receives FDA Orphan Drug Designation For Stem Cell Treatment For Type 1 DiabetesOsiris Therapeutics, Inc. (NASDAQ: OSIR) today announced that it has been granted Orphan Drug designation from the U.S. Food and Drug Administration (FDA) for Prochymal as a treatment for type 1 diabe2010/5/7